# The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) Setting

> **NCT05721365** · — · UNKNOWN · sponsor: **The Christie NHS Foundation Trust** · enrollment: 142 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05721365
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-28
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2023-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05721365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05721365, "The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05721365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*